ARROWHEAD PHARMACEUTICALS, INC. (ARWR) › Operating IncomeARROWHEAD PHARMACEUTICALS, INC. (ARWR) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2010: -$5.83M2011: -$9.83M2012: -$21.09M2013: -$24.59M2014: -$53.28M2015: -$95.97M2016: -$81.74M2017: -$37.00M2018: -$55.94M2019: $61.19M2020: -$93.16M2021: -$149.04M2022: -$178.51M2023: -$205.00M2024: -$601.08M2025: $98.35M$98.35M2010Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025$98.35M+116.4%2024-$601.08M-193.2%2023-$205.00M-14.8%2022-$178.51M-19.8%2021-$149.04M-60.0%2020-$93.16M-252.2%2019$61.19M+209.4%2018-$55.94M-51.2%2017-$37.00M+54.7%2016-$81.74M+14.8%2015-$95.97M-80.1%2014-$53.28M-116.7%2013-$24.59M-16.6%2012-$21.09M-114.5%2011-$9.83M-68.5%2010-$5.83M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share